Yonghe Medical Group Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
114.00
-276.00
-646.00
-127.00
253.00
259.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
109.00
37.00
110.00
-145.00
92.00
117.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
532.00
249.00
-10.00
-128.00
522.00
561.00
Cash Flow from Investing Activities
-74.00
-57.00
260.00
-756.00
-233.00
-160.00
Cash Flow from Financing Activities
-233.00
-311.00
-202.00
-385.00
1,243.00
-173.00
Net Cash Inflow / Outflow
224.00
-119.00
42.00
-1,164.00
1,534.00
228.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
-5.00
105.00
2.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Yonghe Medical Group Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
114.36190491933
81.834
33.00
39.75%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
109.434915246137
-29.27
138.00
473.88%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
532.575807137389
192.167
340.00
177.14%
Cash Flow from Investing Activities
-74.4134865587622
65.892
-139.00
-212.93%
Cash Flow from Financing Activities
-233.082509265595
-278.699
45.00
16.37%
Net Cash Inflow / Outflow
224.858568545405
-4.412
228.00
5196.52%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.221242767627416
16.228
-16.00
-101.36%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 113.64% vs 2,406.02% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
532.58
249.28
113.64%






